$AVNI
ARVANA INC

2024 Q4 Form 10-Q Financial Statement

#000171328224001369 Filed on November 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $6.134K $10.58K
YoY Change -42.02%
Cost Of Revenue $20.82K
YoY Change
Gross Profit -$10.24K
YoY Change
Gross Profit Margin -96.82%
Selling, General & Admin $106.9K
YoY Change 126.61%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.713K $5.851K
YoY Change 14.73%
% of Gross Profit
Operating Expenses $101.8K $127.7K
YoY Change -20.31% 170.75%
Operating Profit -$95.64K -$117.1K
YoY Change -18.35% 148.32%
Interest Expense $15.59K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$6.078K -$3.594K
YoY Change 69.12%
Pretax Income -$120.7K
YoY Change 155.94%
Income Tax
% Of Pretax Income
Net Earnings -$101.7K -$120.7K
YoY Change -15.75% 155.93%
Net Earnings / Revenue -1658.2% -1141.09%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 107.8M shares 107.8M shares 107.8M shares
Diluted Shares Outstanding 107.8M shares 107.8M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.290K
YoY Change -98.46%
Cash & Equivalents $9.257K $3.286K
Short-Term Investments
Other Short-Term Assets $100.00 $5.100K
YoY Change -98.04%
Inventory
Prepaid Expenses
Receivables $8.000K
Other Receivables $0.00
Total Short-Term Assets $9.357K $16.39K
YoY Change -42.9% -92.34%
LONG-TERM ASSETS
Property, Plant & Equipment $143.2K $166.9K
YoY Change -14.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $169.2K $192.9K
YoY Change -12.26%
TOTAL ASSETS
Total Short-Term Assets $9.357K $16.39K
Total Long-Term Assets $169.2K $192.9K
Total Assets $178.6K $209.3K
YoY Change -14.66% -2.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.02K
YoY Change 197.64%
Accrued Expenses $79.22K
YoY Change 684.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $769.1K $46.11K
YoY Change 1567.92%
Total Short-Term Liabilities $1.233M $201.1K
YoY Change 512.9% 349.22%
LONG-TERM LIABILITIES
Long-Term Debt $879.6K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $134.2K $879.6K
YoY Change -84.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.233M $201.1K
Total Long-Term Liabilities $134.2K $879.6K
Total Liabilities $1.367M $1.081M
YoY Change 26.49% 2313.72%
SHAREHOLDERS EQUITY
Retained Earnings -$37.93M -$37.40M
YoY Change 1.42% 3.48%
Common Stock $36.75M $36.54M
YoY Change 0.58% 0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.336K $3.336K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$1.188M -$871.4K
YoY Change
Total Liabilities & Shareholders Equity $178.6K $209.3K
YoY Change -14.66% -2.21%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$101.7K -$120.7K
YoY Change -15.75% 155.93%
Depreciation, Depletion And Amortization $6.713K $5.851K
YoY Change 14.73%
Cash From Operating Activities -$49.48K
YoY Change -2.54%
INVESTING ACTIVITIES
Capital Expenditures $5.740K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$5.740K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 39.86K
YoY Change -84.16%
NET CHANGE
Cash From Operating Activities -49.48K
Cash From Investing Activities -5.740K
Cash From Financing Activities 39.86K
Net Change In Cash -15.36K
YoY Change -107.65%
FREE CASH FLOW
Cash From Operating Activities -$49.48K
Capital Expenditures $5.740K
Free Cash Flow -$55.22K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84111
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
899-1072
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107839299 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9257 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22071 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
100 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5100 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
9357 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
27171 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
143243 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
163378 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26000 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
169243 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
840188 usd
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3336 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3336 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1188388 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-962126 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178600 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
216549 usd
CY2024Q3 AVNI Revenues Charter Income
RevenuesCharterIncome
6134 usd
AVNI Revenues Charter Income
RevenuesCharterIncome
19964 usd
us-gaap Other Operating Income
OtherOperatingIncome
0 usd
us-gaap Other Operating Income
OtherOperatingIncome
0 usd
CY2024Q3 us-gaap Revenues
Revenues
6134 usd
CY2023Q3 us-gaap Revenues
Revenues
10580 usd
CY2023Q3 us-gaap Depreciation
Depreciation
5851 usd
us-gaap Depreciation
Depreciation
20135 usd
us-gaap Depreciation
Depreciation
17552 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
69885 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
93061 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
295475 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
307459 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
14131 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
13828 usd
us-gaap Professional Fees
ProfessionalFees
36636 usd
us-gaap Professional Fees
ProfessionalFees
56872 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
101770 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
127713 usd
us-gaap Operating Expenses
OperatingExpenses
379048 usd
us-gaap Operating Expenses
OperatingExpenses
405267 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-95636 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-117133 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-359084 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-381633 usd
CY2024Q3 us-gaap Lease Income
LeaseIncome
12000 usd
CY2023Q3 us-gaap Lease Income
LeaseIncome
12000 usd
us-gaap Lease Income
LeaseIncome
36000 usd
us-gaap Lease Income
LeaseIncome
32000 usd
CY2024Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
520 usd
CY2023Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
0 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
549 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
5 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
18598 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15594 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
54439 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
42759 usd
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-120727 usd
us-gaap Net Income Loss
NetIncomeLoss
-376974 usd
us-gaap Net Income Loss
NetIncomeLoss
-1163396 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001113313
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity File Number
EntityFileNumber
0-30695
dei Entity Registrant Name
EntityRegistrantName
ARVANA INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0618509
dei Entity Address Address Line1
EntityAddressAddressLine1
299 Main Street
dei Entity Address Address Line2
EntityAddressAddressLine2
13th Floor
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
189378 usd
CY2024Q3 us-gaap Assets
Assets
178600 usd
CY2023Q4 us-gaap Assets
Assets
216549 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
112415 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
100849 usd
CY2024Q3 AVNI Due To Related Party Current
DueToRelatedPartyCurrent
1200 usd
CY2023Q4 AVNI Due To Related Party Current
DueToRelatedPartyCurrent
46200 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
769145 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
79438 usd
CY2024Q3 AVNI Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
350000 usd
CY2023Q4 AVNI Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
112000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1232760 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
338487 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
134228 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
840188 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
134228 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1366988 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1178675 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107845554 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107845554 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
107847 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
107847 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36641016 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36490304 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37933915 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37556941 usd
CY2024Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
-1185052 usd
CY2023Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
-958790 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6255 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6255 shares
CY2023Q3 AVNI Revenues Charter Income
RevenuesCharterIncome
10580 usd
AVNI Revenues Charter Income
RevenuesCharterIncome
23634 usd
CY2024Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 usd
CY2023Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 usd
us-gaap Revenues
Revenues
19964 usd
us-gaap Revenues
Revenues
23634 usd
CY2024Q3 AVNI Cost Of Sales
CostOfSales
11041 usd
CY2023Q3 AVNI Cost Of Sales
CostOfSales
14973 usd
AVNI Cost Of Sales
CostOfSales
26802 usd
AVNI Cost Of Sales
CostOfSales
23384 usd
CY2024Q3 us-gaap Depreciation
Depreciation
6713 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-771009 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6078 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3594 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17890 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-781763 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-101714 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107839299 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107839299 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107839299 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107839299 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-801252 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50542 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-120727 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-871437 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1132102 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
45428 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-101714 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1188388 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
104495 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
187464 usd
us-gaap Net Income Loss
NetIncomeLoss
-1163396 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-871437 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-962126 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
150712 usd
us-gaap Net Income Loss
NetIncomeLoss
-376974 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1188388 usd
us-gaap Net Income Loss
NetIncomeLoss
-376974 usd
us-gaap Net Income Loss
NetIncomeLoss
-1163396 usd
us-gaap Depreciation
Depreciation
20135 usd
us-gaap Depreciation
Depreciation
17552 usd
us-gaap Share Based Compensation
ShareBasedCompensation
150712 usd
us-gaap Share Based Compensation
ShareBasedCompensation
187464 usd
AVNI Loss On Purchase Of Assets
LossOnPurchaseOfAssets
0 usd
AVNI Loss On Purchase Of Assets
LossOnPurchaseOfAssets
771009 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
8000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11566 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
44542 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
193000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
2056 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3439 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-148773 usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
-0 usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
5743 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
50000 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
4089 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51654 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
70766 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
-0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
-0 usd
AVNI Payments On Loans Payable
PaymentsOnLoansPayable
16253 usd
AVNI Payments On Loans Payable
PaymentsOnLoansPayable
9418 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16253 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61348 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-12814 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-139079 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22071 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142365 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9257 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3286 usd
us-gaap Interest Paid Net
InterestPaidNet
48685 usd
us-gaap Interest Paid Net
InterestPaidNet
22318 usd
us-gaap Notes Issued1
NotesIssued1
0 usd
us-gaap Notes Issued1
NotesIssued1
700000 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
234904 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zrR0ZnpIUJdh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zjomfK6B4Eg2">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates include the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences.</span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zIuvAnmYblN6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zznS1rXkEJJh">Concentration of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash. The Company maintains cash in bank accounts that, at times, may exceed federally insured limits. At June 30, 2024 and December 31, 2023 respectively, the Company did not have any cash in excess of the insured FDIC limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank account.</span></p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7950000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7950000 shares
CY2023Q3 us-gaap Depreciation
Depreciation
5851 usd
us-gaap Depreciation
Depreciation
17552 usd
us-gaap Net Income Loss
NetIncomeLoss
-376974 usd
us-gaap Net Income Loss
NetIncomeLoss
-1163396 usd
CY2024Q3 AVNI Working Capital
WorkingCapital
1223403 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37933915 usd
CY2023 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
771009 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
4089 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
5100 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
178706 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Commercial Fishing License
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommercialFishingLicense
26000 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
213895 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
4910 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
644 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Payable To Affiliates
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayableToAffiliates
62634 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Notes Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable
166716 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
234904 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
750000 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesNet
-21009 usd
CY2023Q1 AVNI Business Combination Loss On Asset Acquisition
BusinessCombinationLossOnAssetAcquisition
728991 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
187347 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
187347 usd
CY2024Q3 AVNI Accumulated Depreciation Depletion And Amortization Property Plant And Equipments
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipments
37391 usd
CY2023Q4 AVNI Accumulated Depreciation Depletion And Amortization Property Plant And Equipments
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipments
23969 usd
CY2024Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
149956 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
163378 usd
us-gaap Depreciation
Depreciation
20135 usd
us-gaap Depreciation
Depreciation
17552 usd
CY2024Q3 us-gaap Depreciation
Depreciation
6713 usd
CY2023Q3 us-gaap Depreciation
Depreciation
5851 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Short Term Lease Payments
ShortTermLeasePayments
4000 usd
CY2024Q3 us-gaap Lease Income
LeaseIncome
12000 usd
us-gaap Lease Income
LeaseIncome
36000 usd
CY2023Q3 us-gaap Lease Income
LeaseIncome
12000 usd
us-gaap Lease Income
LeaseIncome
32000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
12000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
52000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
64000 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
1253373 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1031626 usd
CY2024Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
769145 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
79438 usd
CY2024Q3 AVNI Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
350000 usd
CY2023Q4 AVNI Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
112000 usd
CY2024Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
134228 usd
CY2023Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
840188 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
77621 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1069136 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9076 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7730 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8287 usd
CY2024Q3 AVNI Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
81523 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
1253373 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30000 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1200 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1200 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
193000 usd
CY2023 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
AVNI Notes Issued Interest Bearing
NotesIssuedInterestBearing
300000 usd
AVNI Notes Issued Non Interest Bearing
NotesIssuedNonInterestBearing
50000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107845554 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107845554 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7950000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
600000 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
150712 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
249952 usd
AVNI Allocated Share Based Compensation Expense Remaining
AllocatedShareBasedCompensationExpenseRemaining
201909 usd
AVNI Share Based Compensation Expense Remainder Of Fiscal Year
ShareBasedCompensationExpenseRemainderOfFiscalYear
45428 usd
AVNI Share Based Compensation Expense Next Twelve Months
ShareBasedCompensationExpenseNextTwelveMonths
151848 usd
AVNI Share Based Compensation Expense Year Two
ShareBasedCompensationExpenseYearTwo
2527 usd
AVNI Share Based Compensation Expense Year Three
ShareBasedCompensationExpenseYearThree
2106 usd
AVNI Allocated Share Based Compensation Expense Remaining
AllocatedShareBasedCompensationExpenseRemaining
201909 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001713282-24-001369-index-headers.html Edgar Link pending
0001713282-24-001369-index.html Edgar Link pending
0001713282-24-001369.txt Edgar Link pending
0001713282-24-001369-xbrl.zip Edgar Link pending
avni-20240930.xsd Edgar Link pending
avni093024form10q.htm Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
avni-20240930_lab.xml Edgar Link unprocessable
avni-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
avni093024form10q_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
avni-20240930_cal.xml Edgar Link unprocessable
avni-20240930_def.xml Edgar Link unprocessable